267 related articles for article (PubMed ID: 24249731)
1. Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity.
Moreno C; Prieto P; Macías Á; Pimentel-Santillana M; de la Cruz A; Través PG; Boscá L; Valenzuela C
J Immunol; 2013 Dec; 191(12):6136-46. PubMed ID: 24249731
[TBL] [Abstract][Full Text] [Related]
2. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation.
Kure I; Nishiumi S; Nishitani Y; Tanoue T; Ishida T; Mizuno M; Fujita T; Kutsumi H; Arita M; Azuma T; Yoshida M
J Pharmacol Exp Ther; 2010 Feb; 332(2):541-8. PubMed ID: 19846590
[TBL] [Abstract][Full Text] [Related]
3. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
[TBL] [Abstract][Full Text] [Related]
4. Pattern of Kv beta subunit expression in macrophages depends upon proliferation and the mode of activation.
Vicente R; Escalada A; Soler C; Grande M; Celada A; Tamkun MM; Solsona C; Felipe A
J Immunol; 2005 Apr; 174(8):4736-44. PubMed ID: 15814698
[TBL] [Abstract][Full Text] [Related]
5. Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.
Hashimoto A; Hayashi I; Murakami Y; Sato Y; Kitasato H; Matsushita R; Iizuka N; Urabe K; Itoman M; Hirohata S; Endo H
J Rheumatol; 2007 Nov; 34(11):2144-53. PubMed ID: 17918787
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of lipoxin A4 receptor by thromboxane A2 signaling in RAW246.7 cells in vitro and bleomycin-induced lung fibrosis in vivo.
Sato Y; Kitasato H; Murakami Y; Hashimoto A; Endo H; Kondo H; Inoue M; Hayashi I
Biomed Pharmacother; 2004; 58(6-7):381-7. PubMed ID: 15271420
[TBL] [Abstract][Full Text] [Related]
7. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes associated with the ERK1/2 and NF-κB pathways.
Hu F; Liu XX; Wang X; Alashkar M; Zhang S; Xu JT; Zhong XL; He MW; Feng AP; Chen HX
J Dermatol Sci; 2015 Jun; 78(3):181-8. PubMed ID: 25847211
[TBL] [Abstract][Full Text] [Related]
8. Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages.
Vicente R; Escalada A; Coma M; Fuster G; Sánchez-Tilló E; López-Iglesias C; Soler C; Solsona C; Celada A; Felipe A
J Biol Chem; 2003 Nov; 278(47):46307-20. PubMed ID: 12923194
[TBL] [Abstract][Full Text] [Related]
9. Lipoxin A4 inhibits acute edema in mice: implications for the anti-edematogenic mechanism induced by aspirin.
Menezes-de-Lima O; Kassuya CA; Nascimento AF; Henriques Md; Calixto JB
Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):123-35. PubMed ID: 16939877
[TBL] [Abstract][Full Text] [Related]
10. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
Parkinson JF
Inflamm Allergy Drug Targets; 2006 Apr; 5(2):91-106. PubMed ID: 16613568
[TBL] [Abstract][Full Text] [Related]
11. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
Romano M; Maddox JF; Serhan CN
J Immunol; 1996 Sep; 157(5):2149-54. PubMed ID: 8757340
[TBL] [Abstract][Full Text] [Related]
12. Dual role of lipoxin A4 in pneumosepsis pathogenesis.
Sordi R; Menezes-de-Lima O; Horewicz V; Scheschowitsch K; Santos LF; Assreuy J
Int Immunopharmacol; 2013 Oct; 17(2):283-92. PubMed ID: 23816538
[TBL] [Abstract][Full Text] [Related]
13. Activation of P2RY11 and ATP release by lipoxin A4 restores the airway surface liquid layer and epithelial repair in cystic fibrosis.
Higgins G; Buchanan P; Perriere M; Al-Alawi M; Costello RW; Verriere V; McNally P; Harvey BJ; Urbach V
Am J Respir Cell Mol Biol; 2014 Aug; 51(2):178-90. PubMed ID: 24588705
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of K+ currents in the C8-B4 microglial cell line and their regulation by microglia activating stimuli.
Moussaud S; Lamodière E; Savage C; Draheim HJ
Cell Physiol Biochem; 2009; 24(3-4):141-52. PubMed ID: 19710528
[TBL] [Abstract][Full Text] [Related]
15. Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microglia.
Nguyen HM; Grössinger EM; Horiuchi M; Davis KW; Jin LW; Maezawa I; Wulff H
Glia; 2017 Jan; 65(1):106-121. PubMed ID: 27696527
[TBL] [Abstract][Full Text] [Related]
16. Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4.
Planagumà A; Titos E; López-Parra M; Gaya J; Pueyo G; Arroyo V; Clària J
FASEB J; 2002 Dec; 16(14):1937-9. PubMed ID: 12368230
[TBL] [Abstract][Full Text] [Related]
17. Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.
Colby JK; Gott KM; Wilder JA; Levy BD
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):25-33. PubMed ID: 26039320
[TBL] [Abstract][Full Text] [Related]
18. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis.
Hachicha M; Pouliot M; Petasis NA; Serhan CN
J Exp Med; 1999 Jun; 189(12):1923-30. PubMed ID: 10377187
[TBL] [Abstract][Full Text] [Related]
19. Lipoxin A4 protects against lipopolysaccharide-induced sepsis by promoting innate response activator B cells generation.
Cheng Q; Wang Z; Ma R; Chen Y; Yan Y; Miao S; Jiao J; Cheng X; Kong L; Ye D
Int Immunopharmacol; 2016 Oct; 39():229-235. PubMed ID: 27494686
[TBL] [Abstract][Full Text] [Related]
20. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release.
Gronert K; Gewirtz A; Madara JL; Serhan CN
J Exp Med; 1998 Apr; 187(8):1285-94. PubMed ID: 9547339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
